BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 5 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,075,686 | -28.8% | 522,203 | -0.8% | 0.14% | -67.6% |
| Q3 2022 | $1,510,000 | +10.4% | 526,247 | 0.0% | 0.44% | +67.2% |
| Q2 2022 | $1,368,000 | -44.0% | 526,247 | +12.0% | 0.26% | -43.9% |
| Q1 2022 | $2,444,000 | +36.9% | 469,950 | +19.8% | 0.47% | +176.3% |
| Q4 2021 | $1,785,000 | +47.6% | 392,212 | +54.1% | 0.17% | -71.9% |
| Q3 2021 | $1,209,000 | +571.7% | 254,437 | +154.4% | 0.60% | +824.6% |
| Q2 2021 | $180,000 | – | 100,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 122,084 | $361,369 | 0.12% |
| K.J. Harrison & Partners Inc | 170,750 | $505,420 | 0.10% |
| Redmond Asset Management, LLC | 150,000 | $426,000 | 0.07% |
| ARMISTICE CAPITAL, LLC | 375,001 | $1,110,000 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |